… to develop mucoadhesive rivastigmine loaded in chitosan and … were optimized to obtain
chitosan nanoparticles having the … This analysis was performed to evaluate the mucoadhesive …

… PLGA-b-PEG diblock copolymer-based nanoparticles were loaded with the diabetes drug
… The inherent hydrophobic and electrostatic characteristics of nanoparticles are widely …

… the characteristics of DxC surface modified and unmodified lipid/PLGA hybrid NPs prepared
… Hence, the optimization in this work focused on the control of the supersaturation level. A …

… methods demonstrate that they need further optimization prior to human use. … PBCA
curcumin NPs (ApoE3-CPBCA) for enhancing cellular uptake as well as photostability. Prepared …

… used for NC administration, providing an analysis of the advantages and disadvantages of
each … NC surface modification appears to be a key strategy to optimise drug delivery by the in …

… osteoarthritis, with optimal results achieved through the use of liposomes prepared in precise
… Poly(lactic-coglycolic acid) (PLGA) nanoparticles loaded with galantamine were created …

… In addition, the possibility to optimize NP biophysical and biological (ie target-specific …
progressive and irreversible neurodegenerative disorder characterized by memory loss, instability …

… loaded PLGA nanoparticles have been prepared with an … rivastigmine than regular rivastigmine
loaded liposomes. The IN … formulation that could deliver optimal doses of nicotinamide to …

… It is characterized by cerebral microvascular endothelial tight … nanoparticles’; ‘Brain + PLGA
nanoparticles’; ‘Brain + PBCA … PBCA based NPs can be prepared by either polymerization …

… of nanoparticles in the biological systems. We emphasize on the type of clinically used
nanoparticles … Understanding of the characteristics of nanoparticles and their interactions with the …